Market Size –
The varenicline market size has grown strongly in recent years. It will grow from $1.6 billion in 2023 to $1.7 billion in 2024 at a compound annual growth rate (CAGR) of 6.1%. The growth in the historic period can be attributed to rising smoking cessation initiatives, regulatory approvals and recommendations, effectiveness and safety profiles, increased research and development, and the growing prevalence of smoking-related diseases.
The varenicline market size is expected to see strong growth in the next few years. It will grow to $2.17 billion in 2028 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to advancements in smoking cessation research, expansion into emerging markets, integration with digital health solutions, government support and subsidies, and an increased focus on personalized medicine. Major trends in the forecast period include integration with digital health technologies, the development of combination therapies, personalized smoking cessation plans, government expansion, and insurance coverage.
Order your report now for swift delivery @
https://www.thebusinessresearchcompany.com/report/varenicline-global-market-report
Scope Of Varenicline Market
The Business Research Company’s reports encompass a wide range of information, including:
1. Market Size (Historic and Forecast): Analysis of the market’s historical performance and projections for future growth.
2. Drivers: Examination of the key factors propelling market growth.
3. Trends: Identification of emerging trends and patterns shaping the market landscape.
4. Key Segments: Breakdown of the market into its primary segments and their respective performance.
5. Focus Regions and Geographies: Insight into the most critical regions and geographical areas influencing the market.
6. Macro Economic Factors: Assessment of broader economic elements impacting the market.
Varenicline Market Overview
Market Drivers –
The rising prevalence of smoking addiction is expected to propel the growth of the varenicline market going forward. The easy access to cigarettes and other tobacco products, along with social influences and peer pressure, especially among individuals, contributes to increasing smoking rates. Varenicline is a prescription medication that helps people quit smoking by reducing cravings and withdrawal symptoms while also blocking the pleasurable effects of nicotine. For instance, in July 2022, according to Statistics Canada, a Canada-based government agency, cigarette production increased by 5.8% compared to June 2021. Also, the total number of cigarettes sold rose by 1.3% from May 2022, reaching 1.4 billion in June 2022. Therefore, the rising prevalence of smoking addiction will drive the growth of the varenicline market.
Market Trends –
Major companies operating in the varenicline market are focusing on developing new formulations and delivery methods, such as generic tablets, to expand market leadership across regions and gain a competitive edge. Generic varenicline tablets are non-branded versions of the medication containing varenicline tartrate, which is bioequivalent to the original branded product and used for smoking cessation therapy. For instance, in January 2024, Lupin Limited, an India-based pharmaceutical company, launched new Varenicline tablets in the United States, available in 0.5 mg and 1 mg strengths. These tablets are the generic versions of Chantix tablets (0.5 mg and 1 mg) from P.F. Prism C.V. and are used to assist in smoking cessation treatment.
The varenicline market covered in this report is segmented –
1) By Type: 0.5 Mg Tablets, 1 Mg Tablets
2) By Route Of Administration: Oral, Sublingual, Transdermal
3) By Patient Type: Smokers, Ex Smokers, Pre Quitters
4) By Application: Hospital, Drug Store
Get an inside scoop of the varenicline market, Request now for Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=18493&type=smp
Regional Insights –
North America was the largest region in the varenicline market in 2023. The regions covered in the varenicline market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Key Companies –
Major companies operating in the varenicline market are Pfizer Inc., Biocon Limited, Oyster Point Pharma Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Sandoz International GmbH, Nanjing Clasien Pharmaceutical & Chemical Co. Ltd., Hetero Drugs Limited, Sun Pharmaceutical Industries Ltd, Aurobindo Pharma Limited, Dr. Reddy’s Laboratories Ltd., Cipla Limited, Apotex Inc, Amneal Pharmaceuticals LLC, Lupin Limited, Alkem Laboratories Ltd, Glenmark Pharmaceuticals Limited, Jubilant Life Sciences Limited, Alembic Pharmaceuticals Limited, Torrent Pharmaceuticals Ltd., Medley Pharmaceuticals Ltd, Wockhardt Ltd, Par Pharmaceutical Inc, Torrent Pharmaceuticals Ltd, Cadila Healthcare Limited (Zydus Cadila), Lee Pharma Limited, Viwit Pharmaceuticals Limited, Leading Pharma LLC
Table of Contents
1. Executive Summary
2. Varenicline Market Report Structure
3. Varenicline Market Trends And Strategies
4. Varenicline Market – Macro Economic Scenario
5. Varenicline Market Size And Growth
…..
27. Varenicline Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: [email protected]
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
